Molecular Diagnostics
Study Identifies Optimal Blood Tests for Detection and Treatment of Early Stage Alzheimer’s
A new study has identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting relevant treatment effects. These findings will speed up the development of new therapies that can slow down the disease progression. More...02 Dec 2022
Blood Test for Protein Biomarker Could Detect Pancreatic Cancer at Very Early Stage
A new study has found that in some people diagnosed with pancreatic cancer, levels of a particular substance in their blood can be seen to start rising slowly as early as two years before the cancer was diagnosed. This raises the possibility for future research to find ways to detect the dreaded cancer earlier. More...02 Dec 2022
Blood Tests Could Predict Survival Odds for Patients with Metastatic Cancer
A new study has found that measuring the amount of DNA that has been shed by a tumor compared to the body’s typical amount of DNA, defined as the tumor fraction, may be a new tool to predict survival and guide treatment discussions for patients whose cancer has spread from the breast, prostate, lung or colon. More...30 Nov 2022
First-Ever Blood Test Could Detect Deadly Heart Inflammation Within Hours
Myocarditis, or inflammation of the heart muscle, is a difficult condition to diagnose. Now, the discovery of a molecular signal in the blood could pave the way for the first blood test to be used for diagnosing myocarditis within as little as a year. More...25 Nov 2022
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Host Response Immunoassay Test
MeMed BV
In Other News
Urine-Based, Non-Invasive Molecular Test Accurately Detects Bladder Cancer
Altered Ratios of p53 Isoforms Predict Response of Breast Tumors to Chemotherapy
Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC
Blood Test Could Screen for Changes in Proteins Prior to Breast Cancer Diagnosis
Tumor Biopsies Analysis Performed on Newly-diagnosed B-cell Neoplasms
Acute COVID-19 Infections Are Characterized by Elevated Blood Levels of IL-26
New Tool Assesses Cost of ctDNA Testing
Multiplex Vaginal Panel Identifies Three Distinct Conditions in One Hour
Novel Assay Enables Simultaneous Detection of SMA and SCID in Newborns
Simple Blood Test Could More Than Double Liver Cancer Detection Rate in High-Risk Population
First-Ever Saliva-Based Concussion Test to Be Available in 2023
AI Blood Test Detects Liver Cancer
Non-Invasive Saliva Test Predicts Future Risk for Alzheimer's
A Urine Test for Detection and Management of Cystic Fibrosis
Gene Signature Identifies Patients with Long-term Lyme Disease
Direct Real-Time PCR Protocol Detects Monkeypox Virus
Handheld Diagnostic Lab Offers POC Solution for Future Pandemics
Three-Protein Signature Blood Test Can Detect Undiagnosed Prediabetes
Novel Variant of Phosphorylated Tau Helps Fine Tune Early Diagnosis of Alzheimer’s Disease
POC Molecular Diagnostics Analyzer for Infectious Diseases Provides On-The-Spot Results
Rapid Test for G6PD Deficiency Runs on Toaster-Sized Instrument and Delivers Results in 15 Minutes at POC
New Urine Test Could Detect Childhood Kidney Disease Earlier than Current Assays
Breakthrough Diagnostic Technology Enables Quantitative Five-Minute Tests
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
